APTFM
NVS icon

AGUR Provident & Training Funds Management’s Novartis NVS Stock Holding History

AGUR Provident & Training Funds Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-24,174
Closed -$1.51M – 37
2016
Q1 		$1.51M Buy
+24,174
New +$1.64M 1.04% 23

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

AGUR Provident & Training Funds Management's NVS Position: Q2 2016 in Review

AGUR Provident & Training Funds Management sold out of Novartis (NVS) in Q2 2016, closing a stake of 24,174 shares — an estimated $1.51M sold.

AGUR Provident & Training Funds Management first reported a position in NVS in Q1 2016 and held it in 1 quarter. The position peaked at $1.51M in Q1 2016. 878 funds tracked by Wall St. Rank hold NVS as of Q2 2016.

  • AGUR Provident & Training Funds Management reported no remaining Novartis position as of Q2 2016 after selling out during the quarter.
  • AGUR Provident & Training Funds Management sold 24,174 Novartis shares in Q2 2016, an estimated $1.51M.
  • AGUR Provident & Training Funds Management first reported a position in Novartis in Q1 2016 and held it in 1 quarter.
  • AGUR Provident & Training Funds Management's Novartis position peaked at $1.51M in Q1 2016.
  • 878 funds tracked by Wall St. Rank held Novartis as of Q2 2016.

Based on AGUR Provident & Training Funds Management's 13F filing for Q2 2016, filed 15 Aug 2016.